![Mark Eisner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Eisner
Directeur/Bestuurslid bij
ZURA BIO LIMITED
Vermogen: 110 623 $ op 31-07-2026
Profiel
Dr. Mark Eisner, MD, is Chief Medical Officer bij FibroGen, Inc. Dr. Eisner was voordien werkzaam als Senior Vice President bij Genentech, Inc. en als Professor bij The University of California, San Francisco. Hij behaalde zijn doctoraatsdiploma aan de Stanford University, een doctoraatsdiploma aan de UC Berkeley School of Public Health en een doctoraatsdiploma aan het University of Pennsylvania Medical Center.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 12.774 ( 0,01% ) | 110 623 $ | 31-07-2026 | |
| 25-06-2026 | 0 ( -.--% ) | - $ | 31-07-2026 | |
| 17-06-2026 | 0 ( -.--% ) | - $ | 31-07-2026 |
Actieve functies van Mark Eisner
| Bedrijven | Functie | Begin |
|---|---|---|
| ZURA BIO LIMITED | Directeur/Bestuurslid | 21-02-2026 |
| JADE BIOSCIENCES, INC. | Directeur/Bestuurslid | 25-06-2026 |
The Genentech Foundation
 The Genentech Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Directeur/Bestuurslid | - |
Eerdere bekende functies van Mark Eisner
| Bedrijven | Functie | Einde |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Hoofd Techniek/Wetenschap/O&O | 24-04-2026 |
Sonoma Biotherapeutics, Inc.
 Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | Hoofd Techniek/Wetenschap/O&O | 01-06-2024 |
| KYNTRA BIO, INC. | Hoofd Techniek/Wetenschap/O&O | 08-09-2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Opleiding van Mark Eisner
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
59
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Genentech Foundation
The Genentech Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
UC Berkeley School of Public Health
 UC Berkeley School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania Medical Center
 University of Pennsylvania Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | Health Technology |
Zura Bio Ltd.
 Zura Bio Ltd. BiotechnologyHealth Technology Operates as a multi-asset clinical-stage biotechnology company that focuses on develops novel medicines for immune and inflammatory disorders | Health Technology |
